Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity

This publication has 116 references indexed in Scilit:

• CF-DTI: coarse-to-fine feature extraction for enhanced drug-target interaction prediction
  Health Information Science and Systems, 2025
• Microbiota Transplantation Among Patients Receiving Long-Term Care
  JAMA Network Open, 2025
• Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement
  Clinical Pharmacology & Therapeutics, 2025
• Integration of metabolomics and other omics: from microbes to microbiome
  Applied Microbiology and Biotechnology, 2024
• Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors—The MicroLinf Study
  Hematological Oncology, 2024
• Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
  Cancer Medicine, 2024
• Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
  JAMA Network Open, 2023
• VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection
  JAMA, 2023
• The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis
  Arthritis & Rheumatology, 2020
• Short Chain Fatty Acids are Reduced after Hematopoietic Stem Cell Transplant in Humans and are Associated with Modifications of the Gut Microbiome
  Transplantation and Cellular Therapy, 2018